Product details

This is part of a case series. The (B) case in this two-part series provides a short follow-up to the (A) case, and should be used in conjunction with it. The case illustrates the reflections on EndoArt's cumbersome evolution over the past 8 years and relates the venture's situation as of 2006. The venture's investors are increasingly pressing for a return on their investments. Three options are laid out to proceed from this point: strategic partnership or trade sale, grow the firm aggressively and go for an IPO (initial public offering), or make EndoArt a privately-held stand-alone player. None of these options, however, would happen overnight. Hence, management needs to identify and focus on the immediate issues to increase the value of the small company.